Oncology News and Research

RSS
IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Study: Calcium signaling can help address drug resistance to non-Hodgkin lymphoma

Study: Calcium signaling can help address drug resistance to non-Hodgkin lymphoma

Low-cost intervention can increase self-esteem of young cancer survivors

Low-cost intervention can increase self-esteem of young cancer survivors

Researchers identify key protein required for therapeutic resistance in aggressive breast cancer

Researchers identify key protein required for therapeutic resistance in aggressive breast cancer

New $300,000 grant-funded program to address opioid prescribing for cancer patients

New $300,000 grant-funded program to address opioid prescribing for cancer patients

Study estimates the risk of false positives in colon cancer screening

Study estimates the risk of false positives in colon cancer screening

Scientists discover new principle for activation of cancer genes

Scientists discover new principle for activation of cancer genes

Study shows perinatal outcomes following bariatric surgery between pregnancies

Study shows perinatal outcomes following bariatric surgery between pregnancies

Immunotherapy after CRT is safe in curative treatment of women with node-positive cervical cancer

Immunotherapy after CRT is safe in curative treatment of women with node-positive cervical cancer

‘I feel like I’m in jail’: Hospital alarms torment patients

‘I feel like I’m in jail’: Hospital alarms torment patients

Researchers find new way to interpret blood tests to diagnose pulmonary embolism

Researchers find new way to interpret blood tests to diagnose pulmonary embolism

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Alzheimer's may soon be treated with low dose radiation therapy

Alzheimer's may soon be treated with low dose radiation therapy

Coping with (power) loss: California’s hospitals, clinics, patients face new reality

Coping with (power) loss: California’s hospitals, clinics, patients face new reality

Mcl-1 inhibition blocks cell survival in ER+ breast cancers

Mcl-1 inhibition blocks cell survival in ER+ breast cancers

New way to thwart HIV infection at early stages

New way to thwart HIV infection at early stages

Newly developed personalized vaccine system could delay onset of pancreatic cancer

Newly developed personalized vaccine system could delay onset of pancreatic cancer

Women treated for early-stage breast cancer may develop invasive breast cancer

Women treated for early-stage breast cancer may develop invasive breast cancer

Apoptosis protein API-5 more markedly expressed in chemoresistant triple-negative breast cancer

Apoptosis protein API-5 more markedly expressed in chemoresistant triple-negative breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.